BSE filing, NSE: AARTIDRUGS. Summary written from the filing by ALFA Finder's alert engine.
Aarti Drugs Ltd: key numbers
- Share price
- ₹466.30
- Market cap
- ₹4,256 Cr
- Revenue (annual)
- ₹2,565 Cr
- Net profit (annual)
- ₹194.9 Cr
- P/E (TTM)
- 22.3×Sector 41.3×
- Promoter holding
- 54.07%-0.36% QoQ
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarti Drugs Ltd
All →Aarti Drugs Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue Rs 826.2 Cr (+27% YoY), EBITDA Rs 137.9 Cr (16.6% margin, +370 bps), PAT Rs 82.8 Cr (+83%). Specialty chemicals nearly doubled; formulations grew 58%.
Aarti Drugs Q2 FY27 Results: Net Profit ₹82.8 Cr, Up 83.2% YoY
Aarti Drugs Ltd reported revenue from operations of ₹826.2 Cr (+26.6% YoY) and net profit of ₹82.8 Cr (+83.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹82.8 Cr · +83.2% YoY
Aarti Drugs Board Meeting Date
Aarti Drugs Ltd intimated BSE and NSE of a board meeting on November 3, 2026, to consider audited financial results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results declaration.
Aarti Drugs Other Announcement
The company submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Listing Regulations.
Aarti Drugs Other Announcement
Aarti Drugs has updated its list of authorized personnel for determining materiality of events and making stock exchange disclosures, effective October 1, 2026.
Aarti Drugs Management Change
Aarti Drugs Ltd announced the retirement of Director Uday M. Patil and the appointment of new directors, including Adhish P. Patil as the Managing Director.
Other results update announcements
All →Aelea Commodities Results Update
Aelea Commodities reported H1 FY27 revenue up 42% and EBITDA up 53%. Board approved a proposed Rs.114 crore manufacturing expansion.
Clean Max Enviro Energy Solutions Results Update
CleanMax reported H1 FY27 PAT of ₹120 crore, up six-fold, with Q2 revenue up 37% to ₹728 crore. The results press release reflects strong renewable capacity growth.
Multi Commodity Exchange of India Results Update
MCX reported H1FY27 consolidated revenue of ₹1,502 crore, up 100.8% YoY, and PAT of ₹868 crore. Q2FY27 PAT rose 130.8% YoY to ₹455 crore.
Shanti Gold International Results Update
Shanti Gold reported H1 FY27 revenue of Rs. 1,462.3 crore and PAT of Rs. 80.0 crore. Revenue doubled, but Q2 EBITDA margin compressed to 5.7%.
Fine Organic Industries Results Update
Fine Organic reports Q2 FY27 revenue of ₹729.4 Crore and PAT of ₹152.1 Crore, up 40.1%. Results show strong year-on-year growth across revenue, EBITDA and profit.
Jyoti Structures Results Update
Jyoti Structures reported standalone Q2 FY27 total income up 60.2% to Rs 248.57 crore and PAT of Rs 15.37 crore. The order book stood at Rs 4,219 crore as of September 30, 2026.